The discovery of an unknown cellular pathway has helped scientists and physicians better understand end-stage liver disease and offers a potential target for new therapeutics that could slow or even reverse the disease's progression. Although cirrhosis of the liver is most commonly associated with alcohol or drug abuse, the condition -- marked by scar tissue replacing healthy liver tissue -- also can result from viral hepatitis, obesity and diabetes, as well as certain inherited diseases.